This site is intended for healthcare professionals. Not a healthcare professional? Visit Mill-Klinika
All 2006 2007 2008 2009 2010 2010-2011 2011 2012 2012 2013 2013 2014 2014 2015 2015 2016 2016 2017 2017 2018 2018 2019 2019 Articles Associates Associates - archive CME Collis Williams Contributions Contributors Corporate News Archive Dr Charles Savona-Ventura Dr Ian Ellul Dr Pierre Vassallo e-info Archive e-Learning Events Flame Series Francesco Carelli GSK Issue 1 - 2006 Issue 1 - 2007 Issue 1 - 2008 Issue 1 - 2009 Issue 1 - 2010 Issue 1 - 2011 Issue 1 - 2012 Issue 1 - 2013 Issue 1 - 2014 Issue 1 - 2015 Issue 1 - 2016 Issue 1 - 2017 Issue 1 - 2018 Issue 1 - 2019 Issue 1 - 2020 Issue 1 - 2021 Issue 1 - 2022 Issue 2 - 2006 Issue 2 - 2007 Issue 2 - 2008 Issue 2 - 2009 Issue 2 - 2010 Issue 2 - 2011 Issue 2 - 2012 Issue 2 - 2013 Issue 2 - 2014 Issue 2 - 2015 Issue 2 - 2016 Issue 2 - 2017 Issue 2 - 2018 Issue 2 - 2019 Issue 2 - 2020 Issue 2 - 2021 Issue 2 - 2022 Issue 3 - 2006 Issue 3 - 2007 Issue 3 - 2008 Issue 3 - 2009 Issue 3 - 2010 Issue 3 - 2011 Issue 3 - 2012 Issue 3 - 2013 Issue 3 - 2014 Issue 3 - 2015 Issue 3 - 2016 Issue 3 - 2017 Issue 3 - 2018 Issue 3 - 2019 Issue 3 - 2020 Issue 3 - 2021 Issue 4 - 2006 Issue 4 - 2007 Issue 4 - 2008 Issue 4 - 2009 Issue 4 - 2010 Issue 4 - 2011 Issue 4 - 2012 Issue 4 - 2013 Issue 4 - 2014 Issue 4 - 2015 Issue 4 - 2016 Issue 4 - 2017 Issue 4 - 2018 Issue 4 - 2019 Issue 4 - 2020 Issue 4 - 2021 Issue 5 - 2006 Issue 5 - 2007 Issue 5 - 2008 Issue 5 - 2010 Issue 5 - 2011 Issue 5 - 2012 Issue 5 - 2013 Issue 5 - 2014 Issue 5 - 2015 Issue 5 - 2016 Issue 5 - 2017 Issue 5 - 2018 Issue 5 - 2019 Issue 5 - 2020 Issue 5 - 2021 Issue 5 – 2009 Issue 6 - 2006 Issue 6 - 2007 Issue 6 - 2008 Issue 6 - 2009 Issue 6 - 2010 Issue 6 - 2011 Issue 6 - 2012 Issue 6 - 2013 Issue 6 - 2014 Issue 6 - 2015 Issue 6 - 2016 Issue 6 - 2017 Issue 6 - 2018 Issue 6 - 2019 Issue 6 - 2020 Jamesco Library Magazines Medical News Medical News Archived MMSA Network News Network News Archive News Novartis Novo Nordisk Partners Servier SMS4Health Sponsored Videos Technoline TheSynapse e-Learning TheSynapse Magazines TheSynapse Online TheSynapse Videos Uncategorised Uncategorized Vivian Webinars on Diabetes

New Tresiba® Summary of Product Characteristics: European Commission approves the label expansion to include children with type 1 and type 2 diabetes

In December 2014 Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for expanded use of Tresiba® (insulin degludec) in children and adolescents aged 1-17 years with diabetes. And now, after the approval of the European…

Tresiba (Insulin Degludec): Flexibility in day-to-day dosing time when needed

Poor glucose control in patients with diabetes can ultimately result in diabetic complications that can bedevastating for the patient’s quality of life, life-shortening, and expensive to treat for national healthcare systems.Current expert guidelines on the treatment of type 2 diabetes therefore advocate the addition of…